header("Access-Control-Allow-Origin: *"); ?>
Markers of an intense scarring process in the early phase post- myocardial infarction (MI) are still undetermined, and the identification of patients […]
Aortic valve calcification is a condition in which calcium deposits form on the aortic valve in the heart. These deposits can cause narrowing at the […]
Heart failure with preserved ejection fraction (HFpEF) which results from diastolic dysfunction is a growing epidemiologic problem. However, the […]
Ageing myocardium undergoes structural and functional changes characterized by progressive cardiomyocyte hypertrophy, interstitial fibrosis and […]
Expression vectors encoding human cellular fibronectin variants harboring the alternatively spliced Extra Domains B and/or A (or neither) ; […]
Ischemic conditions are a leading cause of death for both men and women. Ischemia, a condition characterized by reduced blood flow and oxygen to an […]
The present invention relates to a method for providing cardioprotection in a subject who experienced a myocardial infarction comprising administering […]
New anti-atherogenic strategies based on B cell modulation, and suggest that patients currently treated with CD20 antibodies for other immune-mediated […]
The present invention relates to a method for treating MI or AMI in a subject in need thereof comprising a step of administering to said subject a […]
Real time constant amperometric detection of NO in tissues/cells.This gaseous neurotransmitter has a very short half-life (*5 s) and is usually […]